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Here we describe emergent properties of the brain and the key challenges associated with 
modelling them in vitro. Modelling emergent properties of the brain will provide insights into 
brain function, development and disease. 
 
Manuscript 
Many properties of complex systems are emergent: they are the result of the collective 
activities of a system’s components, and yet are strikingly different from any of the properties 
that those individual components bear (Corradini and O’Connor 2010)(McClelland 2010). In 
neuroscience, one obvious example of such a property is consciousness, which somehow 
arises from the collective activities of huge numbers of neurons and their supportive cells. As 
far as anyone can tell, none of the properties of individual neurons resembles consciousness, 
and while consciousness can be affected in predictable ways by drugs and disorders, no 
mechanistic explanation for it has yet been found. The problem of understanding 
consciousness lies in understanding how it emerges from all that underlying non-conscious 
activity. 
Consciousness isn’t the only emergent property relevant to neuroscience. As we increase in 
complexity moving from individual ion channels and membrane proteins to individual 
neurons through to circuits and tissues (Figure 1), we deal repeatedly with systems that, when 
brought together, exhibit properties that are new, interesting and often unexpected. 
Emergence is beginning to be discussed in relation to computational models of neural 
systems (Turkheimer and others 2019), but not in tissue models.  One recent example of 
emergent phenomena occurring in tissue models used human neural progenitor cells (hNPC) 
with amyloid precursor protein (APP) or APP and presenilin 1 (PSEN1) familial Alzheimer’s 
disease (FAD) mutations (Choi and others 2014).  When the cells were grown in 2-
dimensional tissue culture, there was an increased production of amyloid-β, but only in 3-
dimensional cultures were amyloid-β plaques and tau tangles formed (Figure 2).  This change 
in protein organisation emerges from a change in tissue structure and may subsequently lead 
to large changes in neural networks. 
 
Emergent phenomena can occur in ways which are very difficult to anticipate.  For instance, 
Alzheimer’s disease is investigated in various animal models (Sasaguri and others 2017).  
Three APP overexpressing mouse lines (APP/PSEN1, Tg2576, hAPP-J20) were assessed 
with high resolution serial 2-photon tomography of labelled plaques (Figure 3) (Whitesell and 
others 2019).  The APP/PSEN1 and Tg2576 mice, displayed plaques initially in the isocortex, 
followed by olfactory, hippocampal, and cortical subplate regions.  In hAPP-J20 mice, the 
plaque density was highest in the hippocampal areas, followed by the isocortex, with little to 
no plaques formed in the olfactory or cortical subplate areas. Overall, distinct regions were 
identified with high or low plaque accumulation (the lateral visual area within the isocortex 
of APP/PSEN1 mice had relatively higher plaque density compared to other cortical areas, 
while hAPP-J20 mice displayed the densest plaques in the ventral retrosplenial cortex).  This 
work demonstrates that emergent phenomena may not be uniform throughout neural tissue, 
consistent with human studies (Grothe and others 2017).  The spatial and temporal pattern of 
emergent phenomena can also vary between models, and hence the use of an appropriate 
model is crucial in testing the clinical relevance of emergent phenomena. For example, 
despite displaying emergent plaque formation, these knock‐in mice do not exhibit tau 
pathology or neurodegeneration (Sasaguri and others 2017).  While this may be due to the 
limited lifetime of the animal models, it indicates that although APP/PSEN1 mutations 
induce behavioural deficits, the emergence of plaques is not a cause of neurodegeneration in 
these mice. 
 
Neural function is typically investigated through electrophysiological methods.  In tissue 
culture, the electrophysiological behaviour may be relatively homogeneous.  However the 
brain can display distinct patterns of electrophysiological activity.  For instance, 
electrophysiological behaviour of grid cells in the entorhinal cortex exhibit a hexagonal 
topographical structure (Hafting and others 2005).  It is thought that grid cells form the basis 
of spatiotemporal representation of places, routes, and associated experiences during 
behaviour and in memory (Moser and others 2008).  This type of complex neural structure is 
being modelled computationally (Solstad and others 2006) (Tait and others 2018), but is 
largely unreplicated in tissue culture models because biofabrication methods have thus far not 
been able to create realistic neural tissue complexity. 
 
Recognising the role of emergence in neural phenomena is crucial for developing a better 
understanding of the function of healthy brains and the ways in which brain function can be 
affected by disease. Such diseases are often associated with changes that could disrupt 
healthy emergent properties and behaviours, introduce new, harmful ones or display 
emergent symptoms. These changes can include the loss of cell types, the degradation of 
neural networks and the build-up of aggregated proteins, such as amyloid plaques or Lewy 
bodies. Investigating these possibilities requires an understanding of the variety of types of 
emergent properties and behaviours that can be found in the brain. 
Healthy neural function and disease are often investigated through different tissue models. 
These include 2-dimensional and more recently 3-dimensional cell cultures, organoids, tissue 
slices, live animal models and finally human clinical trials.  There are limitations in each of 
these models (Wellbourne-Wood and Chatton 2018). Cell cultures are often composed of a 
single immortalised or primary cell type, although co-cultures of multiple cell types are 
possible.  Immortalised cell lines and different animal models allow investigation of 
biological mechanisms, but differences in genetic sequence lead to vast differences in 
structure, composition and signalling, and thus may have a poor relevance to human disease 
(Götz and others 2018). Human tissue from normal and diseased people can be used to form 
cell cultures and organoids, providing more relevant data on biological mechanisms (Choi 
and others 2014)(Raja and others 2016)(Amin and Paşca 2018).  However, the developmental 
stage of these tissues is not the same as in an adult living being, so the level of neural 
networks and development of aged disease phenotypes in the model are not equivalent to 
those in the target system.  Finally, tissue slices are only feasible after a patient has deceased, 
while the amount of invasive testing allowed during clinical trials is limited for ethical 
reasons.  As a result, a lot of extrapolation is required between different tissue models to 
determine the causes and progression of diseases. 
Successfully extrapolating across different models is possible when those models accurately 
capture the relevant features of individual components. In the simplest cases, the properties of 
individual cells ‘add up’ to the whole brain structure and function. In those cases, 
extrapolations from a simple tissue model are relatively straightforward: the properties we 
study in the tissue model simply have to be magnified to give an appropriate prediction 
concerning the brain.  Complete understanding requires tissue models that are complex 
enough to display similar emergent behaviours themselves: we need to generate the emergent 
properties in the tissue model in order to understand it in the target system. Only then can we 
be confident that our tissue models have captured the relevant underlying features. 
Tissue models involve a wide variety of simplifications compared to real brains, including 
simplifications in cellular structure, network connectivity, morphology, neural function, cell 
type, sensory input and output, and chemical input (Wellbourne-Wood and Chatton 2018). 
Neurons in a tissue model may display certain axon and dendrite structure with various ion 
channels and synapses, but in the whole brain a wider variety of cell types and structures are 
found.  In a tissue model, a limited number of connections are made across the neurons 
present, while in the whole brain, larger neural networks can form, and they can cross 
different brain regions. Tissue models are often a 2-dimensional network, in the brain 3-
dimensional structures form, and in primates and humans, cortical folds provide a very high 
surface area. Tissue models show limited coordinated function, whereas the brain shows 
distinct regions that are able to perform functions such as retaining memory. Tissue models 
are often composed of limited cell types, in the brain, multiple cell types are present which 
will alter neural behaviour. Tissue models have limited sensory input and output, while in the 
brain, connections with other organs such as the eye and to muscles leads to formation of new 
types of connections and feedback mechanisms. Tissue models have limited chemical input, 
while in the brain, hormones and other drugs can affect neural behaviour. In all of these 
cases, simple tissue models omit features that could be most relevant for producing the 
emergent phenomena they are supposed to help us understand. 
Tissue models aren’t the only method for investigating the brain. Computer models are also 
used to understand cellular and network behaviour.  These models balance complexity with 
cost and speed of computation, implementing different mathematical representations of 
cellular or network function. While these models can create some emergent phenomena, they 
are limited by the choice of neural features being modelled (Markram and others 2015).  For 
instance, a model of electrophysiological response in neural networks often does not provide 
mechanistic biochemical information.  Emergent phenomena generated by interactions 
between these features would not arise in such a model. Extrapolation from the model to the 
target system would be hampered by the fact that the model has not captured the relevant 
underlying features. 
The challenge of studying emergence is in anticipating which underlying features are 
relevant, and which simplifications in a model are allowable (Gan and others 2018). 
Emergent phenomena may arise at many different scales, involving interactions of molecules, 
cells, brain regions, organs or organisms.  They may be the result of the number of 
components interacting together (e.g. large numbers of molecules, cells, connections), the 
specific type of components present (e.g. certain types of cells), or their arrangement (e.g. 
within a neural network) (Figure 4).  For instance, in determining the impact of amyloid-β 
plaques and tau tangles in Alzheimer’s disease, and to develop effective treatments, the effect 
of tissue structure must be investigated. 
In order to understand brain diseases and develop effective treatments, we need to develop a 
range of models, covering different cellular, network and cognitive functions (Bassett and 
others 2018).  This is the best way to ensure that the relevant features underlying emergent 
phenomena are captured in our models.  Animal models may display similar neural function, 
however variations in genes may have a large impact on the mechanisms behind this 
behaviour (Götz and others 2018)(Dawson and others 2018).  Cell cultures may show cellular 
structure and the development of synapses, but without other cell types, such as 
oligodendrocytes and microglia, myelination won’t occur and the impact of the immune 
response is omitted (Madhavan and others 2018).  A human derived organoid can display 
some neural structure involving several cell types, but the developmental stage limits cell 
maturation and lack of vasculature limits organoid size, preventing development of large 
neural networks and complex structure (Choi and others 2014)(Amin and Paşca 2018). Only 
by integrating a range of models can we hope to capture the relevant features of a disease 
process (Bassett and others 2018). 
Mapping the degradation in cognitive function with disease progression can provide clues to 
the relevant components underlying emergent phenomena, but it doesn’t eliminate the 
possibility that a more complex mechanism is occurring.  By having a range of models, the 
relevant emergent phenomena promotes understanding of normal brain function and for 
developing treatments for disease (Bassett and others 2018).  One approach is to develop 
new, more complex models that display different emergent phenomena than currently 
available in cell culture.  This will involve controlling the cell number, types and their 
arrangement to determine these effects on emergent properties in neural function and disease.  
This may be achieved by further development of tissue engineering methods such as 3D 
bioprinting (Figure 5) (Zhuang and others 2018).  It will also define the limitations of simpler 
models currently in use.  The outcome will be to incorporate the concepts of emergence into 
tissue modelling in order to understand neural function and neurodegenerative disease. 
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Figure 1: The complexity of tissue increases across different models. Low complexity 
models allow investigation of cellular behaviour, but may not capture sufficient information 












Figure 2: Formation of amyloid-β plaques in 3D culture using differentiated hNPCs with 
FAD mutations. (a) 3D culture protocol, (b) amyloid-β deposits in 6-week differentiated 
control (ReN-G), APP (ReN-GA) or APP/PSEN1 (ReN-mGAP) cells (green, GFP; blue, 
3D6; scale = 25 µm; arrowheads, extracellular amyloid-β deposits; right-most panels, 3D6 





Figure 3: Plaque distribution across cortical layers differs between mouse models. Images 
showing plaques in the parietal cortex of 19-month-old (a) APP/PSEN1, (c) Tg2576, and (e) 
hAPP-J20 mice. Approximate layer boundaries are indicated in text to the right of each image 
(wm = white matter). Scale = 500 μm. The relative plaque density in each cortical layer 
across the entire isocortex is plotted separately for (b) APP/PS1, (d) Tg2576, and (f) hAPP-
J20 mouse lines. Box plots show median and IQR with whiskers extending up to 1.5 times 
the IQR. Outliers are plotted as individual points. Adapted with permission from: (Whitesell 
and others 2019) 
 
Figure 4: Representative diagram showing the relationship between emergent phenomena 
and simplified models across three dimensions. The shaded areas represent groups of systems 
with similar patterns of behaviour. For the inner areas, the behaviours are sufficiently similar 
to allow for reliable extrapolation. Emergent phenomena involve drastic changes in behaviour 


















Figure 5: An overview of current in vitro neural tissue models. Cell biology-based models 
include spheroids and organoids, which are heavily dependent on spontaneous cell 
organization, resulting in a highly variable structure and composition. Engineering-based 
models include scaffold-based and microfluidics, which impose better control over matrix 
organization and tissue structure. Bioprinting combines the strengths of cell biology and 
engineered models by integrating cells, scaffolds and microfluidics into one neural tissue 
model with better quality and consistency. Adapted with permission from: (Zhuang and 
others 2018) 
